Analytical chemistry · 2025
A Novel Lithium Ion-Assisted TPP Approach for Enhanced Target Discovery.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yan Jingwen, Wu Yiying, Zhang Yuyu, Wang Qian, Ma Yafei, Chen Yuting, Zhang Panpan, Zhang Wei, Kong Dezhi
Аннотация
Traditional thermal proteome profiling (TPP) suffers from limitations in detecting membrane and weakly bound proteins, potentially overlooking up to 20% of drug targets. To overcome this, we developed a lithium ion-assisted TPP (Li-TPP) method that significantly enhances protein thermal stability detection. Li-TPP successfully captured thermal shifts in weakly bound proteins like lactate dehydrogenase A (LDHA) and resolved changes within NMDA receptor complexes. Compared to traditional TPP, Li-TPP identified 718 additional proteins (R2 > 0.8, min_slope ≤ -0.06) and significantly increased thermal displacement values (ΔTm ≥ 1.5 °C) in 368 coidentified proteins. Importantly, Li-TPP identified known mania-associated targets like GSK3β as well as novel regulatory proteins such as CRMP2. Functional enrichment analysis revealed that Li-TPP-identified proteins were significantly enriched in pathways critical to bipolar disorder, including microtubule dynamics (MT3 complex), synaptic plasticity (NMDA receptor assemblies), and energy metabolism (ATP-binding proteins). This provides mechanistic insights into lithium's therapeutic action, highlighting its role in stabilizing neuronal energy homeostasis and microtubule architecture. This study demonstrates Li-TPP's superior performance in detecting challenging protein targets and provides a powerful new platform for elucidating drug mechanisms and accelerating the development of multitarget therapeutics for bipolar disorder.